Related Experiment Video

Updated: Feb 2, 2026

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells
08:28

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Published on: February 23, 2024

2.5K

Can one target T-cell ALL?

Adolfo Ferrando1

  • 1Institute for Cancer Genetics, Columbia University, 1130 St Nicholas Ave., ICRC 401B, New York, NY, 10032, USA.

Best Practice & Research. Clinical Haematology
|November 24, 2018
PubMed

Insights

Advances in understanding T-cell acute lymphoblastic leukemia (T-ALL) reveal key drivers, opening new therapeutic avenues. Research explores drugs targeting NOTCH1 and CDKN2A alterations, alongside other targets and immunotherapies for T-ALL treatment.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • T-cell acute lymphoblastic leukemia (T-ALL) is a significant hematologic malignancy.
  • Understanding the molecular underpinnings of T-ALL is crucial for developing effective treatments.

Purpose of the Study:

  • To review the molecular basis of T-ALL.
  • To discuss key genes, pathways, and mechanisms driving T-ALL pathobiology.
  • To identify and discuss potential therapeutic targets for T-ALL.

Main Methods:

  • Literature review of T-ALL pathobiology.
  • Analysis of genetic alterations and their role in T-ALL.
  • Discussion of current and emerging therapeutic strategies.

Main Results:

  • Identification of central genes and pathways driving T-ALL.
  • NOTCH1 and CDKN2A genetic alterations are prevalent and targeted by new therapies.
  • Multiple other therapeutic targets and immunotherapies are under investigation.

Conclusions:

  • Progress in understanding T-ALL molecular drivers offers new therapeutic opportunities.
  • Targeting specific genetic alterations like NOTCH1 and CDKN2A shows promise.
  • Further investigation into diverse therapeutic targets and immunotherapies is warranted for T-ALL treatment.
Keywords:
CDKN2AChimeric antigen receptorGSIGamma secretase inhibitorJAK/STATMutationsNOTCH1NT5C2CARNUP214-ABL1PTENT-ALLT-cell acute lymphoblastic leukemia

More Related Videos

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization10:12

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Published on: May 15, 2018

9.5K
Molecular Imaging to Target Transplanted Muscle Progenitor Cells09:24

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

9.4K

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.4K
What are Cells?01:07

What are Cells?

Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
199.5K
Concentration Cells02:41

Concentration Cells

A concentration cell is a type of a  voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
25.9K